Nuances in Nephrology: Coronary artery revascularization strategy in advanced stage of CKD
Patients with chronic kidney disease (CKD) are at increased risk of cardiovascular diseases and related mortality. In the advanced stages of CKD, cardiovascular disease–related mortality rates are much greater than in earliest stages of CKD and in non-CKD populations.
Invasive interventions such as coronary artery bypass grafting (CABG) and percutaneous coronary interventions (PCI) are commonly and successfully used to treat coronary artery disease, but in advanced CKD, patients may be at an increased risk of adverse events from these interventions, which may directly impact on their outcomes, even after transitioning to end-stage renal disease (ESRD).
In this webinar, we will discuss about advantages and disadvantages of PCI vs CABG in advanced stage of CKD patients in the context or short-term and long-term outcomes based on published research studies.